CARY, N.C., Sept. 2, 2024 /PRNewswire/ — On 28 May 2024, Asahi Kasei Corporation (“Asahi Kasei”) announced a recommended public offer (the “Offer”) to acquire all shares and American Depositary Shares (“ADSs”) in Calliditas Therapeutics AB (publ) (“Calliditas”). The Offer consists of a…